Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

MedComm

Showing results (601-610 of 1,534) with videos related to

Pageof 154
Sort By:
Medcomm|September 19, 2025
PACLseq: A Standalone Diagnostic Method for Ph-Like Acute Lymphoblastic Leukemia Using Nanopore SequencingHang Zhang, Huan Yu, Yanmei Chen, et al.
Medcomm|September 15, 2025
Exosome-Based Therapeutics: A Natural Solution to Overcoming the Blood-Brain Barrier in Neurodegenerative DiseasesMin Sun, Feng Qin, Qian Bu, et al.
Medcomm|May 19, 2025
PRMT5 Promotes Pancreatic Cancer Tumorigenesis via Positive PRMT5/C-Myc Feedback LoopFan Yang, Ping Song, Zhaofeng Xiao, et al.
Medcomm|May 19, 2025
Platelet-to-Neutrophil Ratio: A Novel Prognostic Indicator for Anti-PD-1-Based Therapy in Relapsed/Refractory Hodgkin Lymphoma and Solid TumorsYuting Pan, Xin Zhang, Chunmeng Wang, et al.
Medcomm|May 20, 2025
Immune Reconstitution after Haploidentical Hematopoietic Stem Cell Transplantation with Different Non-T-Cell Depletion ProtocolsXiao-Di Ma, Zheng-Li Xu, Xiao-Jun Huang
Medcomm|July 29, 2025
Camrelizumab, an Anti-PD-1 Monoclonal Antibody, Plus Carboplatin and Nab-Paclitaxel as First-Line Setting for Extensive-Stage Small-Cell Lung Cancer: A Phase 2 Trial and Biomarker AnalysisJia Yu, Deyu Cai, Sha Zhao, et al.
Medcomm|July 29, 2025
Toll-Like Receptors in the Immunotherapy Era: Dual-Edged Swords of Tumor Immunity and Clinical TranslationNueraili Maihemuti, Yueli Shi, Kaiyue Zhang, et al.
Medcomm|July 28, 2025
Macrophages: Subtypes, Distribution, Polarization, Immunomodulatory Functions, and TherapeuticsMengyuan Peng, Niannian Li, Hongbo Wang, et al.
Medcomm|July 24, 2025
A Phosphatidylinositol 3-Kinase Gamma Inhibitor Enhances Anti-Programmed Death-1/Programmed Death Ligand-1 Antitumor Effects by Remodeling the Tumor Immune Microenvironment of Ovarian CancerCaixia Jiang, Rongyu Liu, Zhengyu Li
Medcomm|July 22, 2025
Long-Term High-Fat Diet Affected Bone Marrow Microenvironment During Aging at Single-Cell ResolutionYidan Pang, Siyuan Zhu, Peng Ding, et al.
Pageof 154

Showing results (601-610 of 1,534) with videos related to

Sort By:
Pageof 154
Medcomm|September 19, 2025
PACLseq: A Standalone Diagnostic Method for Ph-Like Acute Lymphoblastic Leukemia Using Nanopore SequencingHang Zhang, Huan Yu, Yanmei Chen, et al.
Medcomm|September 15, 2025
Exosome-Based Therapeutics: A Natural Solution to Overcoming the Blood-Brain Barrier in Neurodegenerative DiseasesMin Sun, Feng Qin, Qian Bu, et al.
Medcomm|May 19, 2025
PRMT5 Promotes Pancreatic Cancer Tumorigenesis via Positive PRMT5/C-Myc Feedback LoopFan Yang, Ping Song, Zhaofeng Xiao, et al.
Medcomm|May 19, 2025
Platelet-to-Neutrophil Ratio: A Novel Prognostic Indicator for Anti-PD-1-Based Therapy in Relapsed/Refractory Hodgkin Lymphoma and Solid TumorsYuting Pan, Xin Zhang, Chunmeng Wang, et al.
Medcomm|May 20, 2025
Immune Reconstitution after Haploidentical Hematopoietic Stem Cell Transplantation with Different Non-T-Cell Depletion ProtocolsXiao-Di Ma, Zheng-Li Xu, Xiao-Jun Huang
Medcomm|July 29, 2025
Camrelizumab, an Anti-PD-1 Monoclonal Antibody, Plus Carboplatin and Nab-Paclitaxel as First-Line Setting for Extensive-Stage Small-Cell Lung Cancer: A Phase 2 Trial and Biomarker AnalysisJia Yu, Deyu Cai, Sha Zhao, et al.
Medcomm|July 29, 2025
Toll-Like Receptors in the Immunotherapy Era: Dual-Edged Swords of Tumor Immunity and Clinical TranslationNueraili Maihemuti, Yueli Shi, Kaiyue Zhang, et al.
Medcomm|July 28, 2025
Macrophages: Subtypes, Distribution, Polarization, Immunomodulatory Functions, and TherapeuticsMengyuan Peng, Niannian Li, Hongbo Wang, et al.
Medcomm|July 24, 2025
A Phosphatidylinositol 3-Kinase Gamma Inhibitor Enhances Anti-Programmed Death-1/Programmed Death Ligand-1 Antitumor Effects by Remodeling the Tumor Immune Microenvironment of Ovarian CancerCaixia Jiang, Rongyu Liu, Zhengyu Li
Medcomm|July 22, 2025
Long-Term High-Fat Diet Affected Bone Marrow Microenvironment During Aging at Single-Cell ResolutionYidan Pang, Siyuan Zhu, Peng Ding, et al.
Pageof 154